US 6998513
Human inflammatory breast carcinoma xenograft capable of lymphovascular invasion and methods for its use
expired A61KA61K2039/505A61K49/0008
Quick answer
US patent 6998513 (Human inflammatory breast carcinoma xenograft capable of lymphovascular invasion and methods for its use) held by The Regents of the University of California expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Feb 14 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K49/0008